RHLD's Q4 Losses Cement Overvaluation Fears, Aligning with DeepValue's Strong Sell Call

What happened

Resolute Holdings reported fourth-quarter 2025 earnings per share of ($0.20) and non-GAAP fee-related earnings per share of ($0.04), revealing continued operational losses despite management's upbeat tone. This aligns with the DeepValue master report's critical view that RHLD's valuation, at 70-80x realistic 2026 fee-related earnings, is unsustainable given its asset-light model reliant on 2.5% fees from GPGI's EBITDA. The report emphasizes RHLD's lack of direct claim on GPGI's assets, minimal cash buffer, and exposure to high leverage and cyclical risks in CompoSecure and Husky segments. Beyond the propaganda, the negative earnings suggest underlying cost inefficiencies or slower-than-expected fee growth, contradicting bullish narratives of rapid scalability. Consequently, these results reinforce the report's 'STRONG SELL' rating, highlighting heightened risk of multiple compression as market euphoria fades.

Implication

The Q4 losses underscore RHLD's inability to generate consistent profits, challenging the bullish narrative of fee-based growth and exposing its dependency on GPGI's volatile EBITDA. With RHLD trading at exorbitant multiples and lacking asset backing, any downturn in GPGI's performance—such as Husky integration issues or stalled deleveraging—could trigger severe share price declines. The master report's bear scenario, with an implied value of $120, gains credibility as earnings miss expectations, suggesting the stock may derate toward more reasonable earnings multiples. Investors should closely monitor upcoming disclosures on Husky's contribution and GPGI's net leverage, as these will directly impact RHLD's fee streams and validate or disprove the operating system's efficacy. Given the high conviction in the sell rating, existing holders might consider profit-taking, while new investors should wait for a material correction below $120 before reassessing entry points.

Thesis delta

The DeepValue report's thesis remains unchanged, as the Q4 earnings confirm the overvaluation and operational risks previously identified, with no shift in the core argument. However, the persistent negative earnings add urgency to the downside scenario, suggesting that multiple compression could accelerate if GPGI's EBITDA growth falters or leverage issues persist. This reinforces the need for caution, but does not alter the fundamental view that RHLD is overpriced relative to its fee economics.